
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
Seeking Alpha5/12/2026Neutral
NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.
| Revenue (TTM) | $12.72M |
| Gross Profit (TTM) | $3.14M |
| EBITDA | $-6.81M |
| Operating Margin | -87.90% |
| Return on Equity | -204.40% |
| Return on Assets | -71.70% |
| Revenue/Share (TTM) | $1.53 |
| Book Value | $0.62 |
| Price-to-Book | 2.91 |
| Price-to-Sales (TTM) | 1.14 |
| EV/Revenue | 1.34 |
| EV/EBITDA | -2.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 72.50% |
| Shares Outstanding | $8.70M |
| Float | $5.79M |
| % Insiders | 26.40% |
| % Institutions | 22.64% |
Volatility is currently contracting

NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NMTC and any ticker you trade — then tracks every position and per-strategy win rate.